The Stemness-High Human Colorectal Cancer Cells Promote Angiogenesis by Producing Higher Amounts of Angiogenic Cytokines via Activation of the Egfr/Akt/Nf-κB Pathway

por Chung, Shin-Yi, Chao, Ta-Chung, Su, Yeu
Publicado 2021

Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells

por Chung, Shin-Yi, Chen, Yen-Hsi, Lin, Pei-Rong, Chao, Ta-Chung, Su, Jung-Chen, Shiau, Chung-Wai, Su, Yeu
Publicado 2018

A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer

por Chung, Shin-Yi, Chang, Yu-Chan, Hsu, Dennis Shin-Shian, Hung, Ya-Chi, Lu, Meng-Lun, Hung, Yi-Ping, Chiang, Nai-Jung, Yeh, Chun-Nan, Hsiao, Michael, Soong, John, Su, Yeu, Chen, Ming-Huang
Publicado 2022

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway

por Chung, Shin-Yi, Hung, Yi-Ping, Pan, Yi-Ru, Chang, Yu-Chan, Wu, Chiao-En, Hsu, Dennis Shin-Shian, Chang, Peter Mu-Hsin, Lu, Meng-Lun, Huang, Chi-Ying F., Su, Yeu, Hsiao, Michael, Yeh, Chun-Nan, Chen, Ming-Huang
Publicado 2021